[1] |
国家食品药品监督管理局.药物研究技术指导原则[M].北京:中国医药科技出版社, 2006:94. |
[2] |
袁伯俊, 廖明阳, 李波.药物毒理学实验方法与技术[M].北京:化学工业出版社, 2007:212. |
[3] |
国家食品药品监督管理局.化学药物长期毒性研究技术指导原则[Z].2005: 3. |
[4] |
国家食品药品监督管理局.药物非临床研究质量管理规范[J].中国医药导刊, 2003, 5(5):364. |
[5] |
KARL-HEINZ DIEHL, ROBIN HULL, DAVID MORTON, et al.A good practice guide to the administration of substances and removal of blood, including routes and volumes[J].J Appl Toxicol, 2001, 21:15. doi: 10.1002/(ISSN)1099-1263 |
[6] |
FISH R, DANNEMAN PJ, BROWN M, et al.Anesthesia and analgesia in laboratory animals[M].2nd ed.San Diego:Academic Press, 2008. |
[7] |
National Research Council.Guide for care and use of laboratory animals[S].8th ed.Washington DC: National Academy Press, 2011. |
[8] |
美国《实验动物饲养管理和使用指南》修订委员会, 美国国家学术研究委员会.实验动物饲养管理和使用指南[M].王建飞, 周艳, 刘吉宏, 等译.8版.上海: 上海科学技术出版社, 2012. |
[9] |
WALLACE HAYES A, KRUGER CL.Hayes' principles and methods of toxicology[M].6th ed.Boca Raton:CRC Press.2014:572. |
[10] |
HARDISTY JF, EUSTIS SL.Toxicologic pathology:a critical stage in study interpretation, in progress in predictive toxicology[M].Amsterdam:Elsevier, 1990:41. |
[11] |
GILL SS, KABANAGH M, CHERRY W, et al.A 28-day gavage toxicity study in male Fischer 344 rats with 2-methylfuran[J].Toxicol Pathol, 2014, 2(42):352. |
[12] |
MARK S.The study pathologist's role in GLP studies:a regulator's perspective[J].Toxicol Pathol, 2014, 42(1):285. doi: 10.1177/0192623313506878 |
[13] |
REICHL FX, SCHWENK M.Regulatory Toxicology[M]//KAUFMANN W, JACOBSEN M.Examination of Organ Toxicity.Berlin Heidelberg: Springer, 2014: 89. |
[14] |
陈力田, 张葆樽, 蒋国彦, 等.内科学原理[M].北京:人民卫生出版社, 2005:116. |
[15] |
DU QS, XIE NZ, HUANG RB.Recent development of peptide drugs and advance on theory and methodology of peptide inhibitor design[J].Med Chem, 2015, 11(3):235. doi: 10.2174/1573406411666141229163355 |